1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Prostacyclin and Prostacyclin Analogs 1.2.3 SGC Stimulators 1.2.4 ERA 1.2.5 PDE-5 1.3 Market by Application 1.3.1 Global Pulmonary Arterial Hypertension (PAH) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pulmonary Arterial Hypertension (PAH) Market Perspective (2016-2027) 2.2 Pulmonary Arterial Hypertension (PAH) Growth Trends by Regions 2.2.1 Pulmonary Arterial Hypertension (PAH) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pulmonary Arterial Hypertension (PAH) Historic Market Share by Regions (2016-2021) 2.2.3 Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Regions (2022-2027) 2.3 Pulmonary Arterial Hypertension (PAH) Industry Dynamic 2.3.1 Pulmonary Arterial Hypertension (PAH) Market Trends 2.3.2 Pulmonary Arterial Hypertension (PAH) Market Drivers 2.3.3 Pulmonary Arterial Hypertension (PAH) Market Challenges 2.3.4 Pulmonary Arterial Hypertension (PAH) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pulmonary Arterial Hypertension (PAH) Players by Revenue 3.1.1 Global Top Pulmonary Arterial Hypertension (PAH) Players by Revenue (2016-2021) 3.1.2 Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Players (2016-2021) 3.2 Global Pulmonary Arterial Hypertension (PAH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pulmonary Arterial Hypertension (PAH) Revenue 3.4 Global Pulmonary Arterial Hypertension (PAH) Market Concentration Ratio 3.4.1 Global Pulmonary Arterial Hypertension (PAH) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension (PAH) Revenue in 2020 3.5 Pulmonary Arterial Hypertension (PAH) Key Players Head office and Area Served 3.6 Key Players Pulmonary Arterial Hypertension (PAH) Product Solution and Service 3.7 Date of Enter into Pulmonary Arterial Hypertension (PAH) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pulmonary Arterial Hypertension (PAH) Breakdown Data by Type 4.1 Global Pulmonary Arterial Hypertension (PAH) Historic Market Size by Type (2016-2021) 4.2 Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Type (2022-2027) 5 Pulmonary Arterial Hypertension (PAH) Breakdown Data by Application 5.1 Global Pulmonary Arterial Hypertension (PAH) Historic Market Size by Application (2016-2021) 5.2 Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027) 6.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type 6.2.1 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) 6.2.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) 6.2.3 North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027) 6.3 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application 6.3.1 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) 6.3.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) 6.3.3 North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027) 6.4 North America Pulmonary Arterial Hypertension (PAH) Market Size by Country 6.4.1 North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) 6.4.2 North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027) 7.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type 7.2.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) 7.2.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) 7.2.3 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027) 7.3 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application 7.3.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) 7.3.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) 7.3.3 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027) 7.4 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country 7.4.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) 7.4.2 Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027) 8.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type 8.2.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027) 8.3 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application 8.3.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027) 8.4 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region 8.4.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027) 9.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type 9.2.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) 9.2.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) 9.2.3 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027) 9.3 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application 9.3.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) 9.3.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) 9.3.3 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027) 9.4 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country 9.4.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) 9.4.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size (2016-2027) 10.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type 10.2.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2027) 10.3 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application 10.3.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2027) 10.4 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country 10.4.1 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Actelion 11.1.1 Actelion Company Details 11.1.2 Actelion Business Overview 11.1.3 Actelion Pulmonary Arterial Hypertension (PAH) Introduction 11.1.4 Actelion Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.1.5 Actelion Recent Development 11.2 Gilead Sciences 11.2.1 Gilead Sciences Company Details 11.2.2 Gilead Sciences Business Overview 11.2.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Introduction 11.2.4 Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.2.5 Gilead Sciences Recent Development 11.3 United Therapeutics 11.3.1 United Therapeutics Company Details 11.3.2 United Therapeutics Business Overview 11.3.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Introduction 11.3.4 United Therapeutics Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.3.5 United Therapeutics Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Introduction 11.4.4 GlaxoSmithKline Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.4.5 GlaxoSmithKline Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Pulmonary Arterial Hypertension (PAH) Introduction 11.5.4 Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Bayer 11.6.1 Bayer Company Details 11.6.2 Bayer Business Overview 11.6.3 Bayer Pulmonary Arterial Hypertension (PAH) Introduction 11.6.4 Bayer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.6.5 Bayer Recent Development 11.7 Arena 11.7.1 Arena Company Details 11.7.2 Arena Business Overview 11.7.3 Arena Pulmonary Arterial Hypertension (PAH) Introduction 11.7.4 Arena Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) 11.7.5 Arena Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Prostacyclin and Prostacyclin Analogs Table 3. Key Players of SGC Stimulators Table 4. Key Players of ERA Table 5. Key Players of PDE-5 Table 6. Global Pulmonary Arterial Hypertension (PAH) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Pulmonary Arterial Hypertension (PAH) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Pulmonary Arterial Hypertension (PAH) Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions (2016-2021) Table 10. Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions (2022-2027) Table 12. Pulmonary Arterial Hypertension (PAH) Market Trends Table 13. Pulmonary Arterial Hypertension (PAH) Market Drivers Table 14. Pulmonary Arterial Hypertension (PAH) Market Challenges Table 15. Pulmonary Arterial Hypertension (PAH) Market Restraints Table 16. Global Pulmonary Arterial Hypertension (PAH) Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Pulmonary Arterial Hypertension (PAH) Market Share by Players (2016-2021) Table 18. Global Top Pulmonary Arterial Hypertension (PAH) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension (PAH) as of 2020) Table 19. Ranking of Global Top Pulmonary Arterial Hypertension (PAH) Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Pulmonary Arterial Hypertension (PAH) Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pulmonary Arterial Hypertension (PAH) Product Solution and Service Table 23. Date of Enter into Pulmonary Arterial Hypertension (PAH) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million) Table 26. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2016-2021) Table 27. Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Pulmonary Arterial Hypertension (PAH) Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Application (2016-2021) Table 31. Global Pulmonary Arterial Hypertension (PAH) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million) Table 34. North America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million) Table 36. North America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size by Country (2022-2027) & (US$ Million) Table 63. Actelion Company Details Table 64. Actelion Business Overview Table 65. Actelion Pulmonary Arterial Hypertension (PAH) Product Table 66. Actelion Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 67. Actelion Recent Development Table 68. Gilead Sciences Company Details Table 69. Gilead Sciences Business Overview Table 70. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Product Table 71. Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 72. Gilead Sciences Recent Development Table 73. United Therapeutics Company Details Table 74. United Therapeutics Business Overview Table 75. United Therapeutics Pulmonary Arterial Hypertension (PAH) Product Table 76. United Therapeutics Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 77. United Therapeutics Recent Development Table 78. GlaxoSmithKline Company Details Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Product Table 81. GlaxoSmithKline Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 82. GlaxoSmithKline Recent Development Table 83. Pfizer Company Details Table 84. Pfizer Business Overview Table 85. Pfizer Pulmonary Arterial Hypertension (PAH) Product Table 86. Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 87. Pfizer Recent Development Table 88. Bayer Company Details Table 89. Bayer Business Overview Table 90. Bayer Pulmonary Arterial Hypertension (PAH) Product Table 91. Bayer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 92. Bayer Recent Development Table 93. Arena Company Details Table 94. Arena Business Overview Table 95. Arena Pulmonary Arterial Hypertension (PAH) Product Table 96. Arena Revenue in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) & (US$ Million) Table 97. Arena Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Pulmonary Arterial Hypertension (PAH) Market Share by Type: 2020 VS 2027 Figure 2. Prostacyclin and Prostacyclin Analogs Features Figure 3. SGC Stimulators Features Figure 4. ERA Features Figure 5. PDE-5 Features Figure 6. Global Pulmonary Arterial Hypertension (PAH) Market Share by Application: 2020 VS 2027 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Pulmonary Arterial Hypertension (PAH) Report Years Considered Figure 10. Global Pulmonary Arterial Hypertension (PAH) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Pulmonary Arterial Hypertension (PAH) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions: 2020 VS 2027 Figure 13. Global Pulmonary Arterial Hypertension (PAH) Market Share by Regions (2022-2027) Figure 14. Global Pulmonary Arterial Hypertension (PAH) Market Share by Players in 2020 Figure 15. Global Top Pulmonary Arterial Hypertension (PAH) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension (PAH) as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension (PAH) Revenue in 2020 Figure 17. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2016-2021) Figure 18. Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Type (2022-2027) Figure 19. North America Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027) Figure 21. North America Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027) Figure 22. North America Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027) Figure 23. United States Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027) Figure 27. Europe Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027) Figure 28. Europe Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027) Figure 29. Germany Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027) Figure 37. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027) Figure 38. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Share by Region (2016-2027) Figure 39. China Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027) Figure 47. Latin America Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027) Figure 48. Latin America Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027) Figure 49. Mexico Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Share by Type (2016-2027) Figure 53. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Share by Application (2016-2027) Figure 54. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Share by Country (2016-2027) Figure 55. Turkey Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Actelion Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 59. Gilead Sciences Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 60. United Therapeutics Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 61. GlaxoSmithKline Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 63. Bayer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 64. Arena Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Actelion Gilead Sciences United Therapeutics GlaxoSmithKline Pfizer Bayer Arena